More News

28 Jul 2021 AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
27 Jul 2021 Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
22 Jul 2021 Mirimus, Inc. Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications
21 Jul 2021 NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering
20 Jul 2021 Junshi Biosciences and Immorna Announce Joint Venture to Develop Innovative Self-Replicating and Conventional mRNA Therapeutics and Vaccines
19 Jul 2021 Successful anti-cancer alliance extended
17 Jul 2021 GC LabCell and GC Cell to Merge, Creating a Premier Cell Therapy Company
16 Jul 2021 Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
15 Jul 2021 PAQ Therapeutics Launches with $30 Million Series A to Develop Novel Therapies through Autophagy-Dependent Degradation
15 Jul 2021 Lilly Announces Acquisition of Protomer Technologies
13 Jul 2021 ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
13 Jul 2021 eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
13 Jul 2021 48Hour Discovery and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals
13 Jul 2021 Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology
13 Jul 2021 Biogen and Innocare Announce License and Collaboration Agreement For Orelabrutinib, an Innovative CNS Penetrant BTK Inhibitor For the Potential Treatment of Multiple Sclerosis
13 Jul 2021 Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
13 Jul 2021 Prothena and Novo Nordisk announce acquisition agreement for Prothena’s ATTR amyloidosis programme
09 Jul 2021 I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms
09 Jul 2021 Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
09 Jul 2021 Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
09 Jul 2021 F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
06 Jul 2021 Eureka Therapeutics Announces New GPRC5D License Agreement with Sanofi to Target Multiple Myeloma
06 Jul 2021 South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology
06 Jul 2021 Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration
02 Jul 2021 Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up